Video Gallery
Noradrenaline
Noradrenaline is synthesised from tyrosine in several different areas of the brain. It is released from synaptic vesicles into the synaptic cleft where it can bind to specific noradrenaline receptors on both the pre- and post-synaptic membrane.
There are two main types of noradrenaline receptor found on the post-synaptic membrane - α1 and ß1. The most important is the ß1 subtype, which has a stimulatory effect on the post-synaptic neuron .
In contrast to the post-synaptic membrane, the main adrenoreceptor sub-type found on the pre-synaptic membrane is the α2 receptor. Activation of this receptor has a negative affect, inhibiting the release of noradrenaline from the pre-synaptic neuron.
Pre-synaptic ß2 receptor activation results in an increased release of noradrenaline from the pre-synaptic neuron. Low levels of noradrenaline in the synaptic cleft cause its activation.
Noradrenaline is either degraded by monoamine oxidase in the pre-synaptic neuron, or by COMT, which is found on the post-synaptic membrane.
Serotonin
Serotonin (5HT) is synthesised in the pre-synaptic neuron from tryptophan and serotonin nerve fibres innervate most of the brain. As noradrenaline, serotonin is released from synaptic vesicles into the synaptic cleft where it can bind to its specific receptors.
The 5HT1A receptor has a negative effect on the propagation of the nerve impulse. The binding of serotonin to this receptor causes the opening of ion channels and activation of other proteins, resulting in the inhibition of the nerve impulse.
As opposed to the 5HT1A receptor, activation of the 2A receptor has a stimulatory effect on nerve impulse transmission, but it is also mediated via ion channels and other proteins.
In contrast to noradrenaline, serotonin is degraded by monoamine oxidase in the pre-synaptic neuron only and cannot be broken down by COMT.
Many mood disorders are associated with reduced levels of serotonin. Therapy preventing the degradation of serotonin is often used for the treatment of these affective disorders.
|